EverSource Wealth Advisors’s Enliven Therapeutics ELVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.26K	Buy	63 +50	+385%	+$1K	﹤0.01%	3662
2025 Q1	$256	Buy	13 +11	+550%	+$217	﹤0.01%	3641
2024 Q4	$45	Buy	+2	New	+$45	﹤0.01%	3650